SCHEMBL1476510

SCHEMBL1476510

C#Cc1ncccc1C(=O)N(C)OC.c1cc2cc-2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.37
PLCG1 P19174 1/20 0.34
DHODH Q02127 4/20 0.34
RORB Q92753 1/20 0.33
CNR2 P34972 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
POLB P06746 1/20 0.32
SLC6A7 Q99884 1/20 0.32
MEN1 O00255 1/20 0.32
PKM P14618 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
ABCB1 P08183 1/20 0.32
ABCC1 P33527 1/20 0.32
LPAR5 Q9H1C0 1/20 0.32
HSD17B2 P37059 1/20 0.32
PIK3CA P42336 2/20 0.32
MTOR P42345 2/20 0.32
JAK2 O60674 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1476697 0.86 MEN1 (0.41) RORBCNR2POLBSLC6A7MEN1
SCHEMBL1477041 0.82 TDP1 (0.45) PLCG1DHODHCNR2POLBMEN1
Hydrochloric Acid SCHEMBL1477231 0.81 TDP1 (0.44) PLCG1DHODHCNR2POLBMEN1
SCHEMBL1477295 0.80 RORB (0.38) PLCG1DHODHRORBMEN1KMT2A
SCHEMBL835282 0.78 KDM4E (0.47) DHODHRORBPKM
SCHEMBL1477415 0.78 PLCG1 (0.37) PLCG1DHODHRORBMEN1PKM
SCHEMBL1479640 0.77 PARP1 (0.47) RORBMEN1KMT2AJAK2
SCHEMBL834846 0.76 TSHR (0.46) MEN1MAPK1HTTKMT2A
Hydrochloric Acid SCHEMBL1476864 0.76 PARP1 (0.46) RORBMEN1KMT2AJAK2
SCHEMBL1476600 0.74 ADRA1A (0.33) PLCG1DHODHRORB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915424-B2 Analgesics; anxiolytic agents ELI LILLY AND COMPANY (US) 2011-03-29 US disclosed
EP-1729771-B1 PYRIDYL DERIVATIVES AND THEIR USE AS MGLU5 RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2009-10-14 EP disclosed
US-20080194647-A1 Pyridyl Derivatives and Their Use as Mglu5 Antagonists ELI LILLY AND COMPANY (US) 2008-08-14 US disclosed
EP-1729771-A1 PYRIDYL DERIVATIVES AND THEIR USE AS MGLU5 RECEPTOR ANTAGONISTS Eli Lilly & Company (US) 2006-12-13 EP disclosed
WO-2005094822-A1 PYRIDYL DERIVATIVES AND THEIR USE AS MGLU5 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2005-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194647-A1 Pyridyl Derivatives and Their Use as Mglu5 Antagonists HRH4, CNR2, CNR1 TRPM8 684/4885PLCG1 2534/4885DHODH 2249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.